Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Global Blood Ther (GBT)

Global Blood Ther (GBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,621,431
  • Shares Outstanding, K 67,476
  • Annual Sales, $ 194,750 K
  • Annual Income, $ -303,090 K
  • 60-Month Beta 0.45
  • Price/Sales 23.73
  • Price/Cash Flow N/A
  • Price/Book 37.67
Trade GBT with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -5.01
  • Most Recent Earnings $-1.26 on 08/08/22
  • Next Earnings Date 11/03/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -1.16
  • Number of Estimates 15
  • High Estimate -0.95
  • Low Estimate -1.51
  • Prior Year -1.13
  • Growth Rate Est. (year over year) -2.65%

Price Performance

See More
Period Period Low Period High Performance
1-Month
67.54 +1.41%
on 09/16/22
68.49 unch
on 10/04/22
+0.69 (+1.02%)
since 09/02/22
3-Month
31.51 +117.36%
on 08/01/22
73.02 -6.20%
on 08/05/22
+35.69 (+108.81%)
since 07/01/22
52-Week
21.65 +216.35%
on 06/13/22
73.02 -6.20%
on 08/05/22
+42.37 (+162.21%)
since 10/04/21

Most Recent Stories

More News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MNRL, STOR, GBT, IRBT

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

MNRL : 32.50 (-1.57%)
STOR : 32.21 (unch)
GBT : 68.49 (+0.01%)
IRBT : 8.73 (-1.36%)
INVESTIGATION ALERT: Halper Sadeh LLC Investigates FBMS, GBT, MVBF

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

FBMS : 25.99 (+1.84%)
GBT : 68.49 (+0.01%)
MVBF : 18.35 (-0.22%)
SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates FTAI, SBTX, CVET, GBT

/PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

FTAI : 107.96 (+2.82%)
SBTX : 5.87 (+1.03%)
CVET : 20.99 (+0.29%)
GBT : 68.49 (+0.01%)
SHAREHOLDER ALERT: Weiss Law Reminds SBTX, CVET, GBT, and MSTR Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

SBTX : 5.87 (+1.03%)
CVET : 20.99 (+0.29%)
GBT : 68.49 (+0.01%)
MSTR : 1,320.19 (-3.35%)
GLOBAL BLOOD THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Global Blood Therapeutics, Inc. - GBT

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Global Blood Therapeutics, Inc. (GBT) (NasdaqGS:...

GBT : 68.49 (+0.01%)
PFE : 27.83 (-1.38%)
SHAREHOLDER ALERT: Weiss Law Reminds LTRY, MSTR, GBT, and PFHD Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

LTRY : 0.8994 (-6.56%)
MSTR : 1,320.19 (-3.35%)
GBT : 68.49 (+0.01%)
PFHD : 28.65 (-0.52%)
SHAREHOLDER ALERT: Weiss Law Reminds CYBE, GBT, PFHD, and BBQ Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

CYBE : 54.00 (unch)
GBT : 68.49 (+0.01%)
PFHD : 28.65 (-0.52%)
BBQ : 17.24 (unch)
SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates AAWW, GBT, CYBE, AVLR

/PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

AAWW : 102.48 (+0.02%)
GBT : 68.49 (+0.01%)
CYBE : 54.00 (unch)
AVLR : 93.48 (+0.03%)
SHAREHOLDER ALERT: Weiss Law Reminds AVLR, CYBE, GBT, and PFHD Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

AVLR : 93.48 (+0.03%)
CYBE : 54.00 (unch)
GBT : 68.49 (+0.01%)
PFHD : 28.65 (-0.52%)
GLOBAL BLOOD THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Global Blood Therapeutics, Inc. - GBT

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Global Blood Therapeutics, Inc. (GBT) (NasdaqGS:...

GBT : 68.49 (+0.01%)
PFE : 27.83 (-1.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops treatments for underserved patient communities.

See More

Key Turning Points

3rd Resistance Point 68.52
2nd Resistance Point 68.50
1st Resistance Point 68.50
Last Price 68.49
1st Support Level 68.48
2nd Support Level 68.46
3rd Support Level 68.46

See More

52-Week High 73.02
Last Price 68.49
Fibonacci 61.8% 53.40
Fibonacci 50% 47.33
Fibonacci 38.2% 41.27
52-Week Low 21.65

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar